The Trump administration has proposed a rule change that would give political appointees greater control over how federal research grants are awarded [1].
This shift in authority could allow the administration to limit specific types of scientific research by altering the criteria for funding. Critics said that moving grant oversight from career scientists to political officials threatens the independence of American science [3].
The proposal, announced in late May 2026 [2], targets the Office of Management and Budget (OMB). Under the new guidelines, officials within the OMB would have increased power to oversee and potentially redirect the distribution of federal funds [4].
The rule would affect billions of dollars in federal research grants [1]. These funds typically support a wide array of scientific inquiries, from medical breakthroughs to environmental studies, across the U.S. government's nationwide grant programs [1, 2].
Administration officials said the change is intended to align grant funding with the administration’s priorities and increase overall oversight of scientific research [1, 2]. By centralizing control, the White House aims to ensure that federal spending reflects the policy goals of the current executive branch [3].
Opponents of the measure said the rule could be used to suppress research that contradicts administration policy. They said that the merit-based peer-review process, the traditional standard for scientific funding, could be undermined by political considerations [3, 4].
The proposal comes as part of a broader effort to increase executive authority over federal agencies and their spending priorities [3].
“The rule would affect billions of dollars in federal research grants”
This proposal represents a significant shift in the governance of U.S. science, moving the decision-making process for funding from a decentralized, expert-led peer-review system to a centralized political one. If implemented, it could create a precedent where scientific inquiry is steered by the ideological priorities of the sitting administration rather than by independent academic or clinical merit.
